Platelet-activating anti-PF4 disorders: An overview.

Abstract in brief

• This text explains that Platelet factor 4 (PF4) is a protein that can be targeted by specific IgG antibodies, leading to immune complex formation on blood cells like platelets, which can activate the clotting process and potentially cause blood clotting disorders, including disseminated intravascular coagulation.
• It describes four main anti-PF4-related disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT (aHIT), spontaneous HIT caused by non-heparin factors, and vaccine-induced immune thrombotic thrombocytopenia (VITT), each with distinct triggers and antibody behaviors.
• VITT is a rare condition linked to certain COVID-19 vaccines using adenovirus vectors, marked by low platelet counts, unusual blood clots (like in brain or abdominal veins), and high-potency anti-PF4 antibodies that activate platelets independently of heparin.]